v3.26.1
Cover Page - shares
6 Months Ended
Jun. 30, 2026
Aug. 03, 2026
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2026  
Document Transition Report false  
Entity File Number 001-38959  
Entity Registrant Name BridgeBio Pharma, Inc.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 84-1850815  
Entity Address, Address Line One 3160 Porter Drive  
Entity Address, Address Line Two Suite 250  
Entity Address, City or Town Palo Alto  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 94304  
City Area Code 650  
Local Phone Number 391-9740  
Title of 12(b) Security Common Stock, par value $0.001 per share  
Trading Symbol BBIO  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   195,487,474
Entity Central Index Key 0001743881  
Document Fiscal Year Focus 2026  
Current Fiscal Year End Date --12-31  
Document Fiscal Period Focus Q2  
Amendment Flag false